GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » BBS-Bioactive Bone Substitutes PLC (OHEL:BONEH) » Definitions » Price-to-Free-Cash-Flow

BBS-Bioactive Bone Substitutes (OHEL:BONEH) Price-to-Free-Cash-Flow : N/A (As of Jun. 13, 2024)


View and export this data going back to 2018. Start your Free Trial

What is BBS-Bioactive Bone Substitutes Price-to-Free-Cash-Flow?

As of today (2024-06-13), BBS-Bioactive Bone Substitutes's share price is €0.417. BBS-Bioactive Bone Substitutes's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 was €-0.22. Hence, BBS-Bioactive Bone Substitutes's Price-to-Free-Cash-Flow Ratio for today is N/A.

The historical rank and industry rank for BBS-Bioactive Bone Substitutes's Price-to-Free-Cash-Flow or its related term are showing as below:

OHEL:BONEH's Price-to-Free-Cash-Flow is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 33.67
* Ranked among companies with meaningful Price-to-Free-Cash-Flow only.

BBS-Bioactive Bone Substitutes's Free Cash Flow per Share for the six months ended in Dec. 2023 was €-0.08. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was €-0.22.

During the past 3 years, the average Free Cash Flow per Share Growth Rate was 15.30% per year. During the past 5 years, the average Free Cash Flow per Share Growth Rate was -1.40% per year.

During the past 9 years, BBS-Bioactive Bone Substitutes's highest 3-Year average Free Cash Flow per Share Growth Rate was 15.30% per year. The lowest was -27.70% per year. And the median was -14.00% per year.


BBS-Bioactive Bone Substitutes Price-to-Free-Cash-Flow Historical Data

The historical data trend for BBS-Bioactive Bone Substitutes's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BBS-Bioactive Bone Substitutes Price-to-Free-Cash-Flow Chart

BBS-Bioactive Bone Substitutes Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Free-Cash-Flow
Get a 7-Day Free Trial Premium Member Only - - - - -

BBS-Bioactive Bone Substitutes Semi-Annual Data
Dec15 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Price-to-Free-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of BBS-Bioactive Bone Substitutes's Price-to-Free-Cash-Flow

For the Medical Devices subindustry, BBS-Bioactive Bone Substitutes's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BBS-Bioactive Bone Substitutes's Price-to-Free-Cash-Flow Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, BBS-Bioactive Bone Substitutes's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where BBS-Bioactive Bone Substitutes's Price-to-Free-Cash-Flow falls into.



BBS-Bioactive Bone Substitutes Price-to-Free-Cash-Flow Calculation

BBS-Bioactive Bone Substitutes's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=0.417/-0.219
=N/A

BBS-Bioactive Bone Substitutes's Share Price of today is €0.417.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. BBS-Bioactive Bone Substitutes's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 was €-0.22.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

BBS-Bioactive Bone Substitutes  (OHEL:BONEH) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


BBS-Bioactive Bone Substitutes Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of BBS-Bioactive Bone Substitutes's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


BBS-Bioactive Bone Substitutes (OHEL:BONEH) Business Description

Traded in Other Exchanges
N/A
Address
Kiviharjunlenkki 6, Oulu, FIN, 90220
BBS-Bioactive Bone Substitutes PLC is a health technology company, that develops, designs, and manufactures bioactive bone-graft substitute implants. Its ortho-biological product ARTEBONE, which is based on tricalcium phosphate and a natural spectrum of bone proteins has the capability of bone regeneration.

BBS-Bioactive Bone Substitutes (OHEL:BONEH) Headlines

No Headlines